Concepedia

Saengsuree Jootar

SJ

45

Publications

1.9K

Citations

24

H-Index

1982

Active since

Affiliations

Ramathibodi Hospital(Current)

Mahidol University

Catholic University of Korea

The Catholic University of Korea Seoul St. Mary's Hospital

Novartis (Switzerland)

Saengsuree Jootar is an author at Ramathibodi Hospital specializing in medicine, hematology, and immunology.

Top concepts

Publications per year

1982–2020

45

Publications

45

Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial

Hagop Kantarjian, Ricardo Pasqüini, Nelson Hamerschlak et al. · Blood · 2007 · 377 citations · Full text

Dasatinib or high‐dose imatinib for chronic‐phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily

Hagop M. Kantarjian, Ricardo Pasqüini, Vincent Lévy et al. · Cancer · 2009 · 211 citations · Full text

Biosimilar recombinant human erythropoietin induces the production of neutralizing antibodies

Kearkiat Praditpornsilpa, Khajohn Tiranathanagul, Pawinee Kupatawintu et al. · Kidney International · 2011 · 106 citations · Full text

, , +7

Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Jae-Yong Kwak, Sung‐Hyun Kim, Suk Joong Oh et al. · Clinical Cancer Research · 2017 · 74 citations

Expanding Nilotinib Access in Clinical Trials (ENACT)

Franck E. Nicolini, Anna Turkina, Zhixiang Shen et al. · Cancer · 2011 · 68 citations · Full text

Rows per page

1–5 of 45